(CercleFinance.com) – Reacting to its publication the day before for the first half of 2022, UBS reaffirms its ‘buy’ recommendation on Aviva with a price target maintained at 445 pence, a target which implies a potential upside of 7% for the action of the British insurer.
In its note summary, the broker points out that operating profit for the period exceeded expectations, driven by the general insurance business, and that share buybacks are expected at the end of 2022 for redistribute surplus capital.
Copyright © 2022 CercleFinance.com. All rights reserved.
The information and analyzes disseminated by Cercle Finance only constitute a decision-making aid for investors. The responsibility of Cercle Finance cannot be held directly or indirectly following the use of information and analyzes by readers. It is recommended that any uninformed person consult a professional adviser before any investment. This indicative information does not in any way constitute an incitement to sell or a solicitation to buy.
Did you like this article ? Share it with your friends with the buttons below.
